Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status: Enrolling
Updated:  12/31/1969
University of Texas - MD Anderson
mi
from
Houston, TX
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status: Enrolling
Updated: 12/31/1969
University of Texas - MD Anderson
mi
from
Houston, TX
Click here to add this to my saved trials
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status: Enrolling
Updated:  12/31/1969
Sentara Norfold General Hospital
mi
from
Norfolk, VA
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status: Enrolling
Updated: 12/31/1969
Sentara Norfold General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status: Enrolling
Updated:  12/31/1969
Al-Essra hospital
mi
from
Amman,
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status: Enrolling
Updated: 12/31/1969
Al-Essra hospital
mi
from
Amman,
Click here to add this to my saved trials
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status: Enrolling
Updated:  12/31/1969
Saint Louis University Hospital
mi
from
Saint Louis, MO
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status: Enrolling
Updated: 12/31/1969
Saint Louis University Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome
Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome
Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
Status: Enrolling
Updated:  12/31/1969
Tennessee State Veterans' Homes
mi
from
Murfreesboro, TN
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility
Status: Enrolling
Updated: 12/31/1969
Tennessee State Veterans' Homes
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™
A Phase 2b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ in Healthy Subjects and Patients With Varying Degrees of Renal Impairment
Status: Enrolling
Updated:  12/31/1969
University of Alabama Birmingham, Division of Nephrology
mi
from
Birmingham, AL
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™
A Phase 2b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ in Healthy Subjects and Patients With Varying Degrees of Renal Impairment
Status: Enrolling
Updated: 12/31/1969
University of Alabama Birmingham, Division of Nephrology
mi
from
Birmingham, AL
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™
A Phase 2b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ in Healthy Subjects and Patients With Varying Degrees of Renal Impairment
Status: Enrolling
Updated:  12/31/1969
ICON Early Phase Services
mi
from
San Antonio, TX
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™
A Phase 2b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ in Healthy Subjects and Patients With Varying Degrees of Renal Impairment
Status: Enrolling
Updated: 12/31/1969
ICON Early Phase Services
mi
from
San Antonio, TX
Click here to add this to my saved trials
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
Status: Enrolling
Updated:  12/31/1969
University of Tennessee Health Science Center
mi
from
Memphis, TN
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
Status: Enrolling
Updated: 12/31/1969
University of Tennessee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
A Phase 1 Pilot Safety and Feasibility Study of Autologous Engineered Urethral
Status: Enrolling
Updated:  12/31/1969
Wake Forest Institute for Regenerative Medicine (WFIRM)
mi
from
Winston-Salem, NC
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
A Phase 1 Pilot Safety and Feasibility Study of Autologous Engineered Urethral
Status: Enrolling
Updated: 12/31/1969
Wake Forest Institute for Regenerative Medicine (WFIRM)
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Disposable Stress Urinary Incontinence Pessary Device Study
Rinovum Subsidiary 2, LLC: Disposable Stress Urinary Incontinence Pessary Device Efficacy and Safety Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Disposable Stress Urinary Incontinence Pessary Device Study
Rinovum Subsidiary 2, LLC: Disposable Stress Urinary Incontinence Pessary Device Efficacy and Safety Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Disposable Stress Urinary Incontinence Pessary Device Study
Rinovum Subsidiary 2, LLC: Disposable Stress Urinary Incontinence Pessary Device Efficacy and Safety Study
Status: Enrolling
Updated:  12/31/1969
Allegheny Health Network/East Suburban OB/GYN
mi
from
Monroeville, PA
Disposable Stress Urinary Incontinence Pessary Device Study
Rinovum Subsidiary 2, LLC: Disposable Stress Urinary Incontinence Pessary Device Efficacy and Safety Study
Status: Enrolling
Updated: 12/31/1969
Allegheny Health Network/East Suburban OB/GYN
mi
from
Monroeville, PA
Click here to add this to my saved trials
Disposable Stress Urinary Incontinence Pessary Device Study
Rinovum Subsidiary 2, LLC: Disposable Stress Urinary Incontinence Pessary Device Efficacy and Safety Study
Status: Enrolling
Updated:  12/31/1969
West Virginia University Medicine
mi
from
Morgantown, WV
Disposable Stress Urinary Incontinence Pessary Device Study
Rinovum Subsidiary 2, LLC: Disposable Stress Urinary Incontinence Pessary Device Efficacy and Safety Study
Status: Enrolling
Updated: 12/31/1969
West Virginia University Medicine
mi
from
Morgantown, WV
Click here to add this to my saved trials
Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1
A Phase 1/2, Single-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of Subcutaneously Administered ALN-GO1 in Healthy Adult Subjects, and Patients With Primary Hyperoxaluria Type 1
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Rochester, MN
Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1
A Phase 1/2, Single-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of Subcutaneously Administered ALN-GO1 in Healthy Adult Subjects, and Patients With Primary Hyperoxaluria Type 1
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1
A Phase 1/2, Single-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of Subcutaneously Administered ALN-GO1 in Healthy Adult Subjects, and Patients With Primary Hyperoxaluria Type 1
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Bordeaux,
Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1
A Phase 1/2, Single-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of Subcutaneously Administered ALN-GO1 in Healthy Adult Subjects, and Patients With Primary Hyperoxaluria Type 1
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Bordeaux,
Click here to add this to my saved trials
A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement
A Randomized Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Medical Center
mi
from
Minneapolis, MN
A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement
A Randomized Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)
Status: Enrolling
Updated:  12/31/1969
UC Irvine Health
mi
from
Irvine, CA
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)
Status: Enrolling
Updated: 12/31/1969
UC Irvine Health
mi
from
Irvine, CA
Click here to add this to my saved trials
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)
Status: Enrolling
Updated:  12/31/1969
Maastricht University Medical Center
mi
from
Maastricht,
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)
Status: Enrolling
Updated: 12/31/1969
Maastricht University Medical Center
mi
from
Maastricht,
Click here to add this to my saved trials
Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions in the Emergency Department
Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions for 3 Common Chief Complaints in the Emergency Department (ED)
Status: Enrolling
Updated:  12/31/1969
George Washington University Hospital
mi
from
Washington,
Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions in the Emergency Department
Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions for 3 Common Chief Complaints in the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
George Washington University Hospital
mi
from
Washington,
Click here to add this to my saved trials
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated:  12/31/1969
Chesapeake Health & Rehabilitation Center
mi
from
Chesapeake, VA
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated: 12/31/1969
Chesapeake Health & Rehabilitation Center
mi
from
Chesapeake, VA
Click here to add this to my saved trials
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated:  12/31/1969
Norfolk Health & Rehabilitation Center
mi
from
Norfolk, VA
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated: 12/31/1969
Norfolk Health & Rehabilitation Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated:  12/31/1969
Insight Therapeutics
mi
from
Norfolk, VA
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated: 12/31/1969
Insight Therapeutics
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated:  12/31/1969
Beth Sholom Village
mi
from
Virginia Beach, VA
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated: 12/31/1969
Beth Sholom Village
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated:  12/31/1969
Westminster-Canterbury on Chesapeake Bay
mi
from
Virginia Beach, VA
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
Status: Enrolling
Updated: 12/31/1969
Westminster-Canterbury on Chesapeake Bay
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence
A Double-Blind Randomised Placebo-Controlled Phase I/IIa Dose Titration Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine up to 30 mg vs Placebo BID in Subjects With Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
Upstate Clinical Research Associates
mi
from
Williamsville, NY
DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence
A Double-Blind Randomised Placebo-Controlled Phase I/IIa Dose Titration Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine up to 30 mg vs Placebo BID in Subjects With Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Upstate Clinical Research Associates
mi
from
Williamsville, NY
Click here to add this to my saved trials
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Urology
mi
from
Los Angeles, CA
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Urology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Urogynecology
mi
from
San Diego, CA
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Urogynecology
mi
from
San Diego, CA
Click here to add this to my saved trials
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
Georgia Center for Women
mi
from
Atlanta, GA
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Georgia Center for Women
mi
from
Atlanta, GA
Click here to add this to my saved trials
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
Regional Urology
mi
from
Shreveport, LA
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Regional Urology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
Institute for Female Pelvic Medicine and Reconstructive Surgery
mi
from
Allentown, PA
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Institute for Female Pelvic Medicine and Reconstructive Surgery
mi
from
Allentown, PA
Click here to add this to my saved trials
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
Riddle Hospital, Main Line Health
mi
from
Media, PA
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Riddle Hospital, Main Line Health
mi
from
Media, PA
Click here to add this to my saved trials
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated:  12/31/1969
West Penn Hospital, Allegheny Health Network
mi
from
Pittsburgh, PA
Vesair Continued Access Trial
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
West Penn Hospital, Allegheny Health Network
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Measuring Bladder Volumes Scanning in the ICU
Measuring Bladder Volumes With Ultrasound and Bladder Scanning in the ICU
Status: Enrolling
Updated:  12/31/1969
Barnes-Jewish Hospital / Washington University
mi
from
Saint Louis, MO
Measuring Bladder Volumes Scanning in the ICU
Measuring Bladder Volumes With Ultrasound and Bladder Scanning in the ICU
Status: Enrolling
Updated: 12/31/1969
Barnes-Jewish Hospital / Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Urology Group of Westrn Arkansas
mi
from
Fort Smith, AR
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Urology Group of Westrn Arkansas
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
South Orange County Medical Research Center
mi
from
Laguna Hills, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
South Orange County Medical Research Center
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
California Professionnal Research
mi
from
Newport Beach, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
California Professionnal Research
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
William G. Moseley
mi
from
San Diego, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
William G. Moseley
mi
from
San Diego, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
West Coast Clinical Research
mi
from
Tarzana, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
West Coast Clinical Research
mi
from
Tarzana, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Western Clinical Research
mi
from
Torrance, CA
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Western Clinical Research
mi
from
Torrance, CA
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Urology Research Options
mi
from
Aurora, CO
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Urology Research Options
mi
from
Aurora, CO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Urologic Oncology
mi
from
Aurora, CO
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Urologic Oncology
mi
from
Aurora, CO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Genitourinary Surgical Consultants
mi
from
Denver, CO
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Genitourinary Surgical Consultants
mi
from
Denver, CO
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Connecticut Clincal Research Center
mi
from
Middlebury, CT
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Connecticut Clincal Research Center
mi
from
Middlebury, CT
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Tampa Bay Medical Research Inc.
mi
from
Clearwater, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Tampa Bay Medical Research Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Atlantic Urological Associates
mi
from
Daytona Beach, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Atlantic Urological Associates
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Miami VACM
mi
from
Miami, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Miami VACM
mi
from
Miami, FL
Click here to add this to my saved trials
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated:  12/31/1969
Florida Healthcare Research
mi
from
Ocala, FL
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment
Status: Enrolling
Updated: 12/31/1969
Florida Healthcare Research
mi
from
Ocala, FL
Click here to add this to my saved trials